BALCHEM CORP filed this 8-K on April 30, 2026
BALCHEM CORP - 8-K - 20260430 - CASH_FLOW
Balchem Corporation
Condensed Consolidated Statements of Cash Flows
(Dollars in thousands)
(unaudited)
Three Months Ended March 31,
20262025
Cash flows from operating activities:
   Net earnings $40,285 $37,053 
   Adjustments to reconcile net earnings to net cash provided by operating
      activities:
        Depreciation and amortization12,491 11,014 
        Stock compensation expense 5,356 3,810 
        Other adjustments 970 (105)
        Changes in assets and liabilities(19,041)(15,315)
  Net cash provided by operating activities40,061 36,457 
 
Cash flows from investing activities:
   Capital expenditures and intangible assets acquired(6,252)(5,559)
   Cash paid for acquisitions, net of cash acquired— (323)
   Proceeds from the sale of assets— 
   Investment in affiliates(42)(30)
  Net cash used in investing activities(6,292)(5,912)
Cash flows from financing activities:
   Proceeds from revolving loan52,000 29,000 
   Principal payments on revolving loan(47,000)(29,000)
   Principal payments on finance leases(51)(49)
   Proceeds from stock options exercised6,727 1,668 
   Dividends paid(30,769)(28,263)
   Repurchases of common stock(15,690)(5,325)
  Net cash used in financing activities(34,783)(31,969)
   Effect of exchange rate changes on cash(683)1,810 
(Decrease) increase in cash and cash equivalents(1,697)386 
Cash and cash equivalents, beginning of period74,570 49,515 
Cash and cash equivalents, end of period$72,873 $49,901